Monurol

Monurol is a brand name of fosfomycin, approved by the FDA in the following formulation(s):

MONUROL (fosfomycin tromethamine - for suspension; oral)

• 
  Manufacturer: ZAMBON SPA
  
  Approval date: December 19, 1996
  
  Strength(s): EQ 3GM BASE/PACKET ^[RLD]

Has a generic version of Monurol been approved?

No. There is currently no therapeutically equivalent version of Monurol available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Monurol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Monurol.

See also...

• Monurol Consumer Information (Wolters Kluwer)
• Monurol Consumer Information (Cerner Multum)
• Monurol Advanced Consumer Information (Micromedex)
• Monurol AHFS DI Monographs (ASHP)
• Fosfomycin Consumer Information (Wolters Kluwer)
• Fosfomycin Consumer Information (Cerner Multum)
• Fosfomycin Advanced Consumer Information (Micromedex)
• Fosfomycin Tromethamine AHFS DI Monographs (ASHP)